Policy / Pricing Italy leads the way on child genetic disease diagnosis PharmaphorumA scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems.Policy / PricingRare DiseaseRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) Pharmaphorum A scheme to hasten the diagnosis of children with genetic disorders is achieving strong results and could be a template for national health systems. Policy / PricingRare DiseaseRead full story Post navigation Previous: Asahi Kasei acquires German company AicurisNext: Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy Related Stories Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026 Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026 Policy / Pricing Trump signs order that nearly halves childhood immunisation coverage pharminent August 11, 2026
